Infliximab

• TNF-α inhibitor using human-murine chimeric monoclonal antibody
• Indications include RA and Crohn disease
• Infectious complications include TB, NTM, histoplasmosis, candidiasis, listeriosis, aspergillosis, cryptococcosis, nocardiosis, salmonellosis, toxoplasmosis, brucellosis, bartonellosis, leishmaniasis, coccidiomycosis, CMV, and leprosy